Correlation Between Cogent Biosciences and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Cogent Biosciences and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Kalvista Pharmaceuticals.
Diversification Opportunities for Cogent Biosciences and Kalvista Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cogent and Kalvista is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Cogent Biosciences is expected to under-perform the Kalvista Pharmaceuticals. In addition to that, Cogent Biosciences is 1.02 times more volatile than Kalvista Pharmaceuticals. It trades about -0.39 of its total potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about 0.33 per unit of volatility. If you would invest 877.00 in Kalvista Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 209.00 from holding Kalvista Pharmaceuticals or generate 23.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cogent Biosciences vs. Kalvista Pharmaceuticals
Performance |
Timeline |
Cogent Biosciences |
Kalvista Pharmaceuticals |
Cogent Biosciences and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cogent Biosciences and Kalvista Pharmaceuticals
The main advantage of trading using opposite Cogent Biosciences and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.Cogent Biosciences vs. Larimar Therapeutics | ||
Cogent Biosciences vs. Kura Oncology | ||
Cogent Biosciences vs. Kiniksa Pharmaceuticals | ||
Cogent Biosciences vs. Ideaya Biosciences |
Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | ||
Kalvista Pharmaceuticals vs. Kura Oncology | ||
Kalvista Pharmaceuticals vs. Viridian Therapeutics | ||
Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |